United Therapeutics (UTHR) Interest Coverage Ratio Growth (1y) (2010 - 2026)
United Therapeutics (UTHR) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.00% |
| Mar 31, 2026 | -58.34% |
| Dec 31, 2025 | -278.81% |
| Sep 30, 2025 | -0.38% |
| Jun 30, 2025 | 61.82% |
| Mar 31, 2025 | -32.31% |
| Dec 31, 2024 | 362.82% |
| Sep 30, 2024 | -51.71% |
| Jun 30, 2024 | -47.58% |
| Mar 31, 2024 | 32.30% |
| Dec 31, 2023 | 23.58% |
| Sep 30, 2023 | 7.47% |
| Jun 30, 2023 | 124.11% |
| Mar 31, 2023 | -34.40% |
| Dec 31, 2022 | -66.71% |
| Sep 30, 2022 | 2.27% |
| Jun 30, 2022 | -52.98% |
| Mar 31, 2022 | 461.47% |
| Dec 31, 2021 | 281.75% |
| Sep 30, 2021 | -98.82% |